JD Supra Law

JUNE 13, 2024

In a sealed order that issued on June 11, the Court granted a permanent injunction in favor of Regeneron against Mylan/Biocon in the pending aflibercept BPCIA litigation. . By: Goodwin

Litigation 64

Litigation 64

IP Watchdog

JUNE 27, 2024

Intellectual Property System and the Impact of Litigation Financed by Third-Party Investors and Foreign Entities.” patent litigation. The House Judiciary Subcommittee on Courts, Intellectual Property, and the Internet held a hearing on June 12, 2024 titled the “The U.S.

Litigation 59

Litigation Intellectual Property IP Patent 59

IP Law 360

JUNE 18, 2024

A California federal court has issued a pair of patent eligibility rulings that have ended an inventor's infringement litigation against ride-hailing apps Uber and Lyft.

Litigation 59

Litigation Inventor Patent 59

JD Supra Law

MAY 17, 2024

While courts have yet to definitively rule on the myriad questions raised by the lawsuits, these cases may well signal what’s on the horizon for generative AI litigation. By: K&L Gates LLP

Litigation 76

Litigation 76

JD Supra Law

JUNE 17, 2024

The Texas Patent Litigation Monthly Wrap-Up for May 2024 covers three decisions addressing amendments to infringement contentions, stays while similar actions proceed, and personal jurisdiction over holding companies. By: Fish & Richardson

Litigation 67

Litigation Patent 67

JD Supra Law

JUNE 28, 2024

Aarti Shah of Kilpatrick co-chaired American Conference Institute’s ITC Litigation and Enforcement Conference in May, where many of these changes and trends were discussed. * The ITC Keeps Changing in 2024. The opinions expressed are those of the attorneys and do not necessarily reflect the views of the firm or its clients.

Litigation 58

Litigation 58

IP Law 360

MARCH 28, 2024

Quinn Emanuel Urquhart & Sullivan LLP's office in Chicago has added a 24-year veteran of Kirkland & Ellis LLP who litigates intellectual property, high-profile torts and product liability matters, the firm announced this week.

Litigation 98

Litigation Intellectual Property 98

IP Law 360

JANUARY 1, 2024

A new venue for patent disputes in Europe, potential legal wrangling over the role of artificial intelligence in developing inventions, and continued scrutiny of how litigation funding impacts patent cases are among the litigation topics attorneys will be closely tracking this year.

Litigation 96

Litigation Patent Invention 96

JD Supra Law

APRIL 30, 2024

2023 was an exciting year for Section 337 litigation at the ITC and 2024 is off to an equally interesting start. In this article, Libbie DiMarco reviews five of the most interesting recent developments in Section 337 litigation. Originally published in IP Litigator, March/April 2024, Volume 30, Number 2, pages 31–32.

Litigation 67

Litigation Publishing IP 67

JD Supra Law

JUNE 26, 2024

As Big Molecule Watch continues to push past the bounds of biosimilars and into biologics, we are proud to announce the publication of two additional trackers concerning vaccines: the Vaccine Patent Litigation tracker and the Vaccine Patent PTAB tracker. By: Goodwin

Litigation 64

Litigation Patent 64

IP Law 360

JANUARY 10, 2024

Over the next year and beyond, litigation funding will continue to evolve in ways that affect attorneys and the larger litigation landscape, from the growth of a secondary market for funded claims, to rising interest rates restricting the availability of capital, says Jeffery Lula at GLS Capital.

Litigation 96

Litigation Marketing Marketing 96

JD Supra Law

JUNE 17, 2024

In a sealed order that issued last week, the Court has granted a preliminary injunction against Samsung Bioepis in the aflibercept BPCIA litigation brought by Regeneron. By: Goodwin

Litigation 64

Litigation 64

JD Supra Law

MAY 16, 2024

As we previously reported, in May 2023, Amgen filed a BPCIA complaint in the District of New Jersey alleging infringement based on Sandoz’s denosumab biosimilars of Amgen’s PROLIA and XGEVA (“the Sandoz Denosumab Litigation”). By: Goodwin

Litigation 67

Litigation Reporting 67

IP Watchdog

MAY 25, 2022

Day two of IPWatchdog’s Patent Litigation Masters Program yesterday included panels on IP Finance, Mega Verdicts in Patent Litigation, Expert Witnesses and the Fintiv Saga. During the latter panel, former U.S.

Litigation 124

Litigation Patent IP Intellectual Property 124

IP Law 360

MARCH 20, 2024

Chamber of Commerce about third-party litigation funding, including from potentially hostile foreign entities, state legislatures in Indiana and West Virginia have recently passed bills imposing restrictions on the practice. Amid concerns from the U.S.

Litigation 97

Litigation Law 97

IP Law 360

FEBRUARY 9, 2024

The Western District of Texas also lost its place as the most popular patent litigation venue in the U.S. Attorneys filed fewer patent suits in district courts in 2023 than in any year for more than a decade, and the amount of America Invents Act petitions at the Patent Trial and Appeal Board fell to a 10-year low as well.

Litigation 97

Litigation Patent Invention 97

IP Law 360

MARCH 8, 2024

As increasing numbers of attorneys struggle with stress and mental health issues, business litigators can find protection against burnout by remembering their important role in society — because fulfillment in one’s work isn’t just reserved for public interest lawyers, say Bennett Rawicki and Peter Bigelow at Hilgers Graben.

Business 93

Business Litigation 93

JD Supra Law

JUNE 17, 2024

Aarti Shah of Kilpatrick co-chaired American Conference Institute’s ITC Litigation and Enforcement Conference in May, where many of these changes and trends were discussed. The ITC Keeps Changing in 2024. By: Kilpatrick

Litigation 67

Litigation 67

IP Law 360

JUNE 24, 2024

Nixon Peabody LLP continues to fortify its intellectual property practice with the addition of a former Davis Wright Tremaine LLP litigator, who joins as counsel in the firm's Los Angeles office.

Litigation 52

Litigation Intellectual Property IP 52

IP Law 360

FEBRUARY 8, 2024

while a well-established boutique again took the top spot as the firm defending the most patent litigation during the same period, according to a new Lex Machina report. A Houston-based intellectual property firm filed the most patent suits over the last three years in the U.S.,

Litigation 94

Litigation Intellectual Property Patent Reporting 94

JD Supra Law

APRIL 11, 2024

If, as the saying goes, an ounce of prevention is worth a pound of cure, then the insight provided by our Trade Secret Litigation team is weighty counsel that clients are wise to heed.

Litigation 67

Litigation IP Business 67

JD Supra Law

JANUARY 20, 2023

Welcome to the first edition of the Litigation Gazette. Each quarter, BCLP's Paris team keep you informed of the main litigation news in competition law, commercial litigation, labor law, IP/IT/Data and compliance. In this edition, we cover. By: Bryan Cave Leighton Paisner

Litigation 97

Litigation Editing IP Law 97

JD Supra Law

SEPTEMBER 7, 2023

Two bills recently introduced in Congress could significantly affect the current patent litigation landscape. The bipartisan bills are titled the Patent Eligibility Restoration Act of 2023 and the Promoting and Respecting Economically Vital American Innovation Leadership Act, or the PREVAIL Act. Originally posted in Law360 - August 7, 2023.

Litigation 118

Litigation Patent 118

IP Law 360

JUNE 12, 2024

A congressional committee on Wednesday began discussing whether to require more transparency of third-party litigation funding agreements to stem what lawmakers say are abusive patent lawsuits and national security concerns if hostile foreign governments meddle with cases anonymously.

Litigation 52

Litigation IP Government Patent 52

IPilogue

AUGUST 24, 2022

Litigation is almost always recommended to be avoided , whether because of the sheer amount of time needed to get a court date, the expensive costs for the client and law firm, or the risks associated with receiving an unfavorable judgement. Michelle Mao is an incoming 2L JD student at Osgoode Hall Law school and an IPilogue Writer.

Litigation 106

Litigation Patent Troll Patent Technology 106

JD Supra Law

MAY 10, 2024

As we previously reported, the Judicial Panel on Multidistrict Litigation recently granted Regeneron Pharmaceutical’s (“Regeneron”) motion to establish a multi-district litigation (“MDL”) for its aflibercept BPCIA litigation. By: Goodwin

Litigation 72

Litigation Reporting 72

JD Supra Law

JANUARY 24, 2024

The year 2023 witnessed several developments in Canadian IP litigation. From summary judgment finding its limits to the denial of a permanent injunction for the first time in almost three decades, several cases decided in 2023 contributed to shaping the landscape of IP litigation in Canada.

Litigation 72

Litigation IP 72

JD Supra Law

FEBRUARY 21, 2024

Given that importance, IP owners must occasionally litigate against the unauthorized use of their technology. The costs of such litigation and appurtenant settlements implicate a host of federal income tax issues. Some IP litigants do not consider those tax issues at all, while others aggressively overplay their hand.

Settlement 67

Settlement Technology Litigation Intellectual Property 67

IP Watchdog

APRIL 18, 2024

In patent litigation, damages issues are sometimes treated as an afterthought when compared to the issues of infringement and invalidity. However, achieving a client’s goals requires an attorney to place damages at the center of the litigation strategy from the very beginning. Damages, quite simply, can make or break a case.

Litigation 59

Litigation Patent Patent Infringement Intellectual Property 59

JD Supra Law

JANUARY 18, 2023

As such, they may one day become embroiled in patent litigation, even though such litigation has been rare in the blockchain space. They perform significant work in multiple areas, especially developing crypto financial software systems. By: Kramer Levin Naftalis & Frankel LLP

Litigation 97

Litigation Patent 97

JD Supra Law

APRIL 18, 2024

There’s no question that new patent litigation case filings are down across the board. However, the reason for the downward trend depends on whom you ask. Our attorneys examine the numbers behind the decline and provide their insights and experiences to explain the drop in filings. Questions and Comments: jkurcz@bakerlaw.com.

Litigation 69

Litigation Patent 69

JD Supra Law

FEBRUARY 13, 2024

For those who have not had a chance to attend one of our CLE presentations on Litigation Funding Disclosure, this IAM article provides a glimpse of the complex landscape for defendants seeking discovery on litigation funding topics in their cases. Litigation funding can significantly impact the parties’ ability to reach settlement.

Litigation 61

Litigation Settlement 61

JD Supra Law

NOVEMBER 30, 2023

Litigation over standard-essential patents, or SEPs, can be a cyclical phenomenon, where litigation follows a generational change in technology. We saw it with 3G and 4G technology, where each generational change led to a flurry of litigation focused on smartphones. Originally published in Law360 August 2023.

Litigation 78

Litigation Licensing Publishing Technology 78

IP Law 360

JUNE 11, 2024

Fish & Richardson PC has strengthened its intellectual property litigation group in Houston with a familiar face who left the firm over a year ago to trot the globe with his wife.

Litigation 52

Litigation Intellectual Property IP 52

IP Law 360

MAY 21, 2024

Carlton Fields has hired its fourth intellectual property litigator in New York in the past year, adding a former Zuber Lawler partner to the practice as a shareholder.

Litigation 52

Litigation Intellectual Property IP 52

JD Supra Law

MAY 16, 2023

Here, we update our previous article on the state of blockchain patents and patent litigation with an overview of the landscape of patents and patent litigations in the space. Blockchain had a challenging year but continues to grow as a technology with broad applicability. By: Kramer Levin Naftalis & Frankel LLP

Litigation 98

Litigation Patent Technology 98

JD Supra Law

APRIL 30, 2024

We previously reported on the litigation brought by ModernaTX, Inc. and Moderna US, Inc. collectively, “Moderna”) against BioNTech SE, BioNTech Manufacturing GmbH, BioNTech US Inc. collectively, “BioNTech”), and Pfizer Inc.

Litigation 69

Litigation Reporting Technology 69